Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel Á. Sanz, Francesco Lo‐Coco, Pierre Fenaux et al.|Blood|2019Cited by 655
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Martin Jädersten et al.|Nature Medicine|2020Cited by 633
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaRaphaël Itzykson, Éric Solary, Olivier Kosmider et al.|Journal of Clinical Oncology|2013Cited by 543
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemiasRaphaël Itzykson, Olivier Kosmider, Thomas Cluzeau et al.|Leukemia|2011Cited by 464
Clonal architecture of chronic myelomonocytic leukemiasRaphaël Itzykson, Éric Solary, Olivier Kosmider et al.|Blood|2013Cited by 268